Yongqi Deng Spent 20 Years Finding Molecules. Then He Built a Company Around the Search.

After two decades inside Schering-Plough and Merck, the medicinal chemist returned to China to turn a mass-spectrometry screening idea into Keythera - and a six-program drug pipeline.